Newsroom
Category
January 4, 2013
A study published this week in the New England Journal of Medicine offers hope of an effective treatment for hepatitis C with fewer ill effects than interferon therapy, which has long been the standard of care.
December 19, 2012
Gene expression initiates protective electrical response
December 11, 2012
ER physicians can discuss variety of health-related topics
December 11, 2012
Results of UT Health Science Center study published in the journal Cancer
December 7, 2012
Studies of how to overcome drug resistance in deadly central nervous system tumors called glioblastomas will propel forward thanks to $755,718 from the Cancer Prevention & Research Institute of Texas.
December 7, 2012
The ability of rapamycin-related drugs to potentially slow the aging process — suggested in animal experiments at The University of Texas Health Science Center San Antonio — has led to establishment of a new San Antonio biotech company, Rapamycin Holdings Inc., which is licensing exclusive rights to intellectual property central to several aspects of the rapamycin-related drugs.